Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC in early chronic spinal cord injury
NCT03521323Phase 2Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Sep 2019
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in spinal cord injury (SCI), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT03521323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03521323.